Search U.S. Product Recalls Database

Showing 741–760 of 3039 results

Sort:

FDR Visionary Suite (Fujifilm) – X-ray Support Defect (2025)

It was found that the shaft for mounting the X-ray tube unit on the support may break. In addition, it was found that the protective parts might not work effectively only when the shaft was broken while being operated toward the front while lifting.

Moderate

FDASep 15, 2025AK, CA, FL +5 more• FUJIFILM Healthcare Americas Corporation

Mixed Nuts Salted (Severn Peanut) – Undeclared Nut (2025)

Undeclared Allergen

Undeclared Tree Nut. The firm discovered that Hazelnuts was not listed in the allergen statement

Class IIModerate

FDASep 15, 2025MA, NY• Severn Peanut Company LLC

Stay Informed

Search Product Recalls

FDR Visionary Suite (Fujifilm) – X-ray Support Defect (2025)

Mixed Nuts Salted (Severn Peanut) – Undeclared Nut (2025)

Bupropion XL Tablets (Graviti) – Tablet Specification Failure (2025)

Carbamazepine Tablets (Amerisource) – Dissolution Issue (2025)

CONSTELLATION Ultrasound (Alcon) – Unspecified Issue (2025)

Mixed Nuts No Salt (Severn Peanut) – Undeclared Nut (2025)

Micronized BPO Gel Cleanser (Private Label Skin Care) – benzene contamination (2025)

Cardiac Workstation 7000 (Philips) – Power Module Failure (2025)

Millenium MPS (GE Medical) – Service End Risk (2025)

Long Grain & Wild Rice (Ben's Original) – Stone Risk (2025)

Cetirizine Hydrochloride Tablets (JB Chemicals) – incorrect tablet imprint (2025)

Cetirizine Hydrochloride Tablets 500ct (JB Chemicals) – incorrect tablet imprint (2025)

Affinity NT Oxygenator (Medtronic) – Gas Transfer Defect (2025)

STA Liatest D-Di (Diagnostica Stago) – D-Dimer Level Underestimation (2025)

Maxicam (GE Medical) – Service End Risk (2025)

Shanghai United CT X-ray System (UIH) – Patient Table Interference (2025)

Millenium MPR (GE Medical) – Service End Risk (2025)

Elscint SPX6 (GE Medical) – Service End Risk (2025)

Elscint Cardial (GE Medical) – Service End Risk (2025)

Sopha Medical Vision (GE Medical) – Service End Risk (2025)